News Daily News Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions L.A. McKeown May 06, 2022
News Daily News Good News and Bad for High-Intensity Statin Use in ASCVD Michael O'Riordan May 05, 2022
News Daily News NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes L.A. McKeown May 03, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Daily News Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy Todd Neale March 07, 2022
News Daily News Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis Yael L. Maxwell March 01, 2022
News Daily News Fewer Diabetic Complications Seen When NOACs Given for AF L.A. McKeown February 22, 2022
News Conference News ISC 2022 Tenecteplase Feasible Up to 24 Hours After Stroke Todd Neale February 15, 2022
News Conference News ISC 2022 ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis Todd Neale February 10, 2022
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Daily News PASCAL Pinpoints Patients With Strokes Causally Related to PFO Yael L. Maxwell December 20, 2021
News Daily News No Uptick in CVD Events After COVID-19 Vaccination in Older Adults Michael O'Riordan November 29, 2021
News Daily News Rivaroxaban Again Linked to More Bleeding vs Other DOACs Caitlin E. Cox October 11, 2021
News Daily News Long-term Anticoagulation After Unprovoked VTE: New Insights Shelley Wood September 13, 2021
News Daily News Switching to Tenecteplase for Stroke Thrombolysis May Boost Outcomes Todd Neale September 09, 2021